Publications — Haemophilus influenzae
Return to Publications Menu
2006 to present:
Erwin AL, Sandstedt SA, Bonthuis PJ, Geelhood JL, Nelson KL, Unrath W CT, Diggle MA, Theodore MJ, Pleatman CR, Mothershed EA, Sacchi CT, Mayer LW, Gilsdorf JR, Smith AL. Analysis of Genetic Relatedness of Haemophilus influenzae Isolates by Multilocus Sequence Typing. J Bacteriol 2007; [In press].
Satola SW. Collins JT. Napier R. Farley MM. Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates. J Clin Microbiol 2007;45(10):3230-8.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2006 - provisional. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib06.pdf
Back to Top
2000-2005:
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2005. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib05.pdf
Kapogiannis BG, Satola S, Keyserling HL, Farley MM. Invasive Infections with H. influenzae Serotype a Containing an IS 1016-bexA Partial Deletion: Possible Association with Virulence. Clin Infect Dis 2005; 41:e97-103.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2004. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib04.pdf
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2003. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib03.pdf
LaClaire LL, Tondella MLC, Beall DS, Nobel CA, Raghunatnan PL, Rosenstein NE, Popovic T, and the ABCs Team Members. Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. J Clin Microbiol 2003;41:1:393-396.
Centers for Disease Control and Prevention. 2002. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2002. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib02.pdf
Ohuabunwo C, Bath S, Bisgard K, Murphy T, Shutt K, Rosenstein N. Progress Toward Elimination of Haemophilus influenzae Type b Invasive Disease Among Infants and Children, United States, 1998--2000. MMWR Morb Mortal Wkly Rep 2002; 51(11); 234-237.
Raghunathan PL, LaClaire LL, Tondella ML, Beall DS, Noble CS, Rosenstein NE, Popovic T. Serotyping discrepancies in Haemophilus influenzae type b disease, United States, 1998-1999. MMWR Morb Mortal Wkly Rep 2002;51(32);706-707.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2001. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib01.pdf.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2000. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib00.pdf.
Back to Top
1995-1999:
Centers for Disease Control and Prevention. Achievements in Public Health, 1900-1999 Impact of Vaccines Universally Recommended for Children - United States, 1990-1999. MMWR Morb Mortal Wkly Rep 1999;48(12);243-248.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1999. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib99.pdf
Jafari HS, Adams WG, Robinson KA, Plikaytis BD, Wenger JD. Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group. Am J Public Health 1999;89:364-368.
Bisgard K, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae disease in the United States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis1998;4:229-237.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1998. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib98.pdf.
Centers for Disease Control and Prevention. Progress Toward Elimination of Haemophilus influenzae Type b Disease Among Infants and Children -- United States, 1987-1997. MMWR Morb Mortal Wkly Rep 1998;47:993-998.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1997. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib97.pdf
Centers for Disease Control and Prevention. Progress Toward Elimination of Haemophilus influenzae type b disease among infants and children -- United States, 1987-1995. MMWR Morb Mortal Wkly Rep 1996;45(42):901-906.
Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM, and the H. Influenzae study group. Invasive Haemophilus influenzae serotype f disease: Clinical and epidemiological characteristics in the Hib vaccine era. Clin Inf Dis 1996;22:1069-1076.
Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae Type b disease among infants and children-United States, 1993-1994. MMWR Morb Mortal Wkly Rep 1995;44(29):545-550.
Back to Top
1988 - 1994:
Centers for Disease Control and Prevention. Progress Toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1993. MMWR 1994;43(8):144-148.
Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, Wenger JD. Decline of childhood Haemophilus influenzae Type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-226.
Farley MM, Stephens DS, Brachman PS Jr, Harvey RC, Smith JD, Wenger JD. Invasive Haemophilus influenzae Disease in Adults: Population-Based Surveillance. Ann Intern Med 1992; 116:806-12.
Farley MM, Stephens DS, Harvey RC, Sikes RK, Wenger JD, and the CDC Meningitis Surveillance Group. Incidence and Clinical Characteristics of Invasive Haemophilus influenzae in Adults. J Infect Dis 1992; 165:S42-43.
Wenger JD, Pierce R, Deaver K, Franklin R, Bosley G, Pigott N, Broome CV. Invasive Haemophilus influenzae disease: A population-based evaluation of the role of capsular polysaccharide serotype. J Infect Dis 1992;165 [Suppl. 1]:S34-35.
Wenger JD, Pierce R, Deaver KA, Plikaytis BD, Facklam RR, Broome CV, and the Haemophilus influenzae Vaccine Efficacy Study Group. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Lancet 1991;338:395-398.
Wenger JD, Harrison LH, Hightower A, Broome CV. Day care characteristics associated with Haemophilus influenzae disease. Am J Public Health 1990;80:1455-8.
Harrison LH, Broome CV, Hightower AW. Haemophilus influenzae type b polysaccharide vaccine: an efficacy study. Pediatrics 1989;84:255-61.
Harrison LH, Broome CV, Hightower AW, Hoppe CC, Makintubee S, Sitze SL, Taylor JA, Gaventa S, Wenger JD. A day care-based study of the efficacy of Haemophilus b polysaccharide vaccine. JAMA 1988;260:1413-1418.
Back to Top
|
